Dirk De Cuyper

863 total citations · 1 hit paper
17 papers, 538 citations indexed

About

Dirk De Cuyper is a scholar working on Immunology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dirk De Cuyper has authored 17 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dirk De Cuyper's work include Psoriasis: Treatment and Pathogenesis (11 papers), Autoimmune Bullous Skin Diseases (5 papers) and Pregnancy and Medication Impact (5 papers). Dirk De Cuyper is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Autoimmune Bullous Skin Diseases (5 papers) and Pregnancy and Medication Impact (5 papers). Dirk De Cuyper collaborates with scholars based in Belgium, United States and United Kingdom. Dirk De Cuyper's co-authors include Luke Peterson, Richard B. Warren, Andrew Blauvelt, Veerle Vanvoorden, Richard G. Langley, Kristian Reich, Christopher L. Cioffi, Cynthia Madden, Bruce Strober and Mark Lebwohl and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Annals of the Rheumatic Diseases.

In The Last Decade

Dirk De Cuyper

16 papers receiving 530 citations

Hit Papers

Bimekizumab versus Secukinumab in Plaque Psoriasis 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bimekizumab versus Secukinumab in Plaque Psoriasis
    2021 230 citations Kristian Reich, Richard B. Warren et al. New England Journal of Medicine profile →

Peers

Dirk De Cuyper
Francesco Loconsole Italy
A. Maza France
Nilgün Atakan Türkiye
Georgia Avgerinou Greece
Federica Ricceri Italy
Lucia Gallo Italy
Richard Woolf United Kingdom
Mark D. Herron United States
D. Sotiriadis Greece
Gabrielle Brown United States
Francesco Loconsole Italy
Dirk De Cuyper
Citations per year, relative to Dirk De Cuyper Dirk De Cuyper (= 1×) peers Francesco Loconsole

Countries citing papers authored by Dirk De Cuyper

Since Specialization
Citations

This map shows the geographic impact of Dirk De Cuyper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk De Cuyper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk De Cuyper more than expected).

Fields of papers citing papers by Dirk De Cuyper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk De Cuyper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk De Cuyper. The network helps show where Dirk De Cuyper may publish in the future.

Co-authorship network of co-authors of Dirk De Cuyper

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk De Cuyper. A scholar is included among the top collaborators of Dirk De Cuyper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk De Cuyper. Dirk De Cuyper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Blauvelt, Andrew, April W. Armstrong, Joseph F. Merola, et al.. (2024). Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials. Journal of the American Academy of Dermatology. 91(1). 72–81. 6 indexed citations
2.
Lebwohl, Mark, Joseph F. Merola, Bruce Strober, et al.. (2024). Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials. Journal of the American Academy of Dermatology. 91(2). 281–289. 2 indexed citations
3.
Gordon, Kenneth B., Richard G. Langley, Richard B. Warren, et al.. (2023). Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials. British Journal of Dermatology. 190(4). 477–485. 14 indexed citations
4.
5.
Blauvelt, Andrew, April W. Armstrong, Joseph F. Merola, et al.. (2023). Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Analysis of Mental Health and Associated Disorders. SKIN The Journal of Cutaneous Medicine. 7(6). s300–s300.
6.
Eyerich, Kilian, Alice B. Gottlieb, Stefano Piaserico, et al.. (2023). 43878 Bimekizumab versus secukinumab for the treatment of nail psoriasis in patients with moderate to severe plaque psoriasis: Results from the BE RADIANT phase 3b trial. Journal of the American Academy of Dermatology. 89(3). AB22–AB22. 1 indexed citations
7.
Kokolakis, Georgios, Richard B. Warren, Bruce Strober, et al.. (2022). Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. British Journal of Dermatology. 188(3). 330–340. 18 indexed citations
8.
Reich, Kristian, Andrew Blauvelt, Mark Lebwohl, et al.. (2021). Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. SKIN The Journal of Cutaneous Medicine. 5(1). s21–s21. 1 indexed citations
9.
Reich, Kristian, Richard B. Warren, Mark Lebwohl, et al.. (2021). Bimekizumab versus Secukinumab in Plaque Psoriasis. New England Journal of Medicine. 385(2). 142–152. 230 indexed citations breakdown →
10.
Warren, Richard B., Andrew Blauvelt, Jerry Bagel, et al.. (2021). Bimekizumab versus Adalimumab in Plaque Psoriasis. New England Journal of Medicine. 385(2). 130–141. 139 indexed citations
11.
Warren, Richard B., Andrew Blauvelt, Jerry Bagel, et al.. (2021). Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). SKIN The Journal of Cutaneous Medicine. 5(1). s15–s15. 2 indexed citations
12.
Clowse, Megan E. B., Douglas C. Wolf, Frauke Förger, et al.. (2015). Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. The Journal of Rheumatology. 42(12). 2270–2278. 59 indexed citations
13.
Mahadevan, Uma, Séverine Vermeire, Douglas C. Wolf, et al.. (2015). Tu1320 Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From Safety Surveillance. Gastroenterology. 148(4). S–858. 8 indexed citations
14.
Förger, Frauke, J. Cush, Douglas C. Wolf, et al.. (2015). OP0018 Pregnancy Outcomes with Trimesters of Maternal Exposure to Certolizumab Pegol: Prospective and Retrospective Reports from Safety Surveillance. Annals of the Rheumatic Diseases. 74. 71–71. 2 indexed citations
15.
Mahadevan, Uma, Séverine Vermeire, David C. Wolf, et al.. (2014). DOP024 Pregnancy outcomes after exposure to certolizumab pegol: Results from safety surveillance. Journal of Crohn s and Colitis. 8. S26–S26. 3 indexed citations
16.
Wolf, Douglas C., Frauke Förger, J. Cush, et al.. (2014). OP0067 Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from Safety Surveillance. Annals of the Rheumatic Diseases. 73. 85–86. 2 indexed citations
17.
Ragaert, Peter, Sam Verbrugghe, Bruno G. De Geest, et al.. (2011). Use of endospore-forming bacteria as an active oxygen scavenger in plastic packaging materials. Innovative Food Science & Emerging Technologies. 12(4). 594–599. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Loconsole Breakdown of academic impact, for papers by A. Maza Breakdown of academic impact, for papers by Nilgün Atakan Breakdown of academic impact, for papers by Georgia Avgerinou Breakdown of academic impact, for papers by Federica Ricceri Breakdown of academic impact, for papers by Lucia Gallo Breakdown of academic impact, for papers by Richard Woolf Breakdown of academic impact, for papers by Mark D. Herron Breakdown of academic impact, for papers by D. Sotiriadis Breakdown of academic impact, for papers by Gabrielle Brown
Rankless by CCL
2026